Transanal Endoscopic Microsurgery (TEMS) for Rectal Cancer: Patient Decision-making, Postoperative Experience and Quality of Life
- PMID: 33622926
- PMCID: PMC8045127
- DOI: 10.21873/invivo.12374
Transanal Endoscopic Microsurgery (TEMS) for Rectal Cancer: Patient Decision-making, Postoperative Experience and Quality of Life
Abstract
Background/aim: Transanal endoscopic microsurgery (TEMS) is a form of minimally invasive surgery for selected rectal cancers. The aim of this study was to explore the factors affecting patients' decision-making concerning the choice of surgical treatment as well as to measure the Quality of Life (QoL) post-TEMS.
Patients and methods: Thirty-four patients with rectal cancer stage T1/T2-N0-M0 that underwent TEMS were studied. The questionnaires used included the Short Form SF12v2, Wexner Score (CCF-FIS) and the Sexual Function Questionnaire (SFQ). The patients' views on experience and treatment decision were obtained with a custom-designed questionnaire. Questionnaires were completed at a mean of 6.9 years following treatment.
Results: The factors that influenced the patients' decisions were: experience satisfaction (p=0.003), postoperative bowel function (p<0.001), lower incontinence score (p=0.020) and agreement of TEMS experience with preoperative information (p=0.049). Treatment experience satisfaction was associated with family support (p=0.034) and agreement with preoperative information (p=0.047), better bowel function (p=0.026) and mental QoL (MCS) (p=0.003).
Conclusion: factors important to patients when reflecting on treatment experience are adequate and reliable information, a good QoL and the presence of family support. Clinicians should incorporate those parameters in their practice when assisting patients in making a surgical treatment choice and provide informed consent on TEMS for rectal cancer.
Keywords: Decision-making; QoL; TEMS; geriatric; incontinence; rectal cancer; sexual functioning.
Copyright© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Conflict of interest statement
None declared.
Figures


Similar articles
-
Quality of Life and Bowel Dysfunction after Transanal Endoscopic Microsurgery for Rectal Cancer: One Third of Patients Experience Major Low Anterior Resection Syndrome.Dig Surg. 2020;37(1):39-46. doi: 10.1159/000496434. Epub 2019 Jun 11. Dig Surg. 2020. PMID: 31185474
-
Transanal endoscopic microsurgery versus laparoscopic lower anterior resection for the treatment of T1-2 rectal cancers.Hepatogastroenterology. 2013 Jun;60(124):727-32. doi: 10.5754/hge12868. Epub 2012 Nov 16. Hepatogastroenterology. 2013. PMID: 23159393 Clinical Trial.
-
Quality of life in non-early rectal cancer treated by neoadjuvant radio-chemotherapy and endoluminal loco-regional resection (ELRR) by transanal endoscopic microsurgery (TEM) versus laparoscopic total mesorectal excision.Surg Endosc. 2016 Feb;30(2):504-511. doi: 10.1007/s00464-015-4232-8. Epub 2015 Jun 5. Surg Endosc. 2016. PMID: 26045097
-
Should the rectal defect be sutured following TEMS/TAMIS carried out for neoplastic rectal lesions? A meta-analysis.Ann R Coll Surg Engl. 2020 Nov;102(9):647-653. doi: 10.1308/rcsann.2020.0135. Epub 2020 Jun 15. Ann R Coll Surg Engl. 2020. PMID: 32538129 Free PMC article.
-
Quality of life and anorectal function after transanal surgery for rectal cancer. A literature review.Ann Ital Chir. 2019;90:138-144. Ann Ital Chir. 2019. PMID: 31182703 Review.
Cited by
-
Micro video incentive nursing intervention improves the psychological state and quality of life in patients with rectal cancer after enterostomy.Am J Transl Res. 2023 Mar 15;15(3):2040-2048. eCollection 2023. Am J Transl Res. 2023. PMID: 37056851 Free PMC article.
-
Non-gastrointestinal symptom burden following colorectal cancer treatment-a systematic review.Support Care Cancer. 2024 Oct 3;32(10):699. doi: 10.1007/s00520-024-08903-7. Support Care Cancer. 2024. PMID: 39361213
-
Use of patient-reported experience and outcome measures within the colorectal cancer care continuum: a scoping review.J Cancer Surviv. 2024 Apr 16. doi: 10.1007/s11764-024-01595-2. Online ahead of print. J Cancer Surviv. 2024. PMID: 38627293 Review.
References
-
- Cancer Research UK. Bowel cancer incidence statistics. Cancer Research UK, 2015 . Available at: https://www.cancerresearchuk.org/health-professional/cancer-statistics/s... [Last accessed on 9th December 2020]
-
- Cancer Research UK Survival | Bowel cancer | Cancer Research UK . Available at:https://www.cancerresearchuk.org/aboutcancer/bowel-cancer/survival [Last accessed on 22nd August 2020]
-
- Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen Y-J, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Gurski L, Freedman-Cass DA. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(7):874–901. doi: 10.6004/jnccn.2018.0061. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources